Ironwood Pharmaceuticals and Allergan ave reached an agreement with Aurobindo Pharma, resolving patent litigation brought in response to Aurobindo Pharma’s abbreviated new drug application (ANDA) seeking approval to market a generic version of Lizness (linaclotide) prior to the expiration of the companies’ applicable patents. The settlement with Aurobindo is the second patent infringement settlement the companies have…